Our contribution to COVID19 battle



Who we are:


PhRMA Innovation Forum (PIF)

PhRMA Innovation Forum (PIF) represents 26 leading Research and Development Companies, which work together to meet the medical needs of patients in Greece, to help them have a long, healthy and productive life.

PIF member companies represent 60% of the Greek pharmaceutical market and the majority of domestic investments in international clinical trials with over € 90 million in investments in Greece over the last five years, while employing 3,000 highly trained professionals.

Our common vision is to use our global experience and ensure that patients in Greece have adequate and timely access to the treatment they need.

Our commitment is to work with all relevant sectors in order to contribute to the creation of a fair, democratic, transparent, stable and sustainable health system, which will also reward pharmaceutical innovation.